2024 Global Clinical Lab Services Report: Trends & Innovations – ResearchAndMarkets.com
The “Worldwide Market for Clinical Laboratory Services, 9th Edition” has been newly listed on ResearchAndMarkets.com. Gain insights into demographic and disease trends, new developments, company performance, mergers and acquisitions, and national expansions. This report is essential for navigating the evolving…
TauRx Submits UK Application for HMTM in Alzheimer’s Treatment
TauRx Pharmaceuticals Ltd, a leader in tau-based research for Alzheimer’s disease (AD), has submitted a UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM) to treat mild cognitive impairment (MCI-AD) and mild to moderate dementia stages caused by Alzheimer’s disease.…
Anteris and v2vmedtech Introduce Next-Gen Mitral & Tricuspid Repair System, VClip™, After Animal Study Success
Anteris Technologies Ltd (ASX: AVR) and v2vmedtech, inc. have announced the completion of the concept lock phase for their next-generation Transcatheter Edge to Edge Repair (TEER) system, VClip™. This milestone marks a crucial advancement toward initiating a first-in-human study for…
HAYA Therapeutics Co-Founders Win First Struengmann Award
HAYA Therapeutics, SA, a company specializing in RNA-guided precision medicines focused on long non-coding RNAs (lncRNAs), has announced that its Co-Founders, Samir Ounzain and Daniel Blessing, have been awarded the inaugural Andreas & Thomas Struengmann Award. Dr. Ounzain, CEO and…
Freeflow Ventures Secures $90M for Early Stage Deep Tech Investments
Freeflow Ventures, a venture capital firm specializing in science-driven solutions to human and planetary health challenges, has raised $50M in new funds, comprising a $35M Fund Two and a $15M Opportunity Fund. This brings Freeflow’s total assets under management to…
Mitel Wins 2024 Virtual Workspace Platform of The Year Award
Mitel®, a global leader in business communications, has announced that its Virtual Care Collaboration Service (VCCS) has earned the prestigious title of “Virtual Workspace Platform of the Year” in the 5th Annual RemoteTech Breakthrough Awards by RemoteTech Breakthrough, a prominent…
Biosimilars Training: Prepare for Growth Amid Biologics Patent Expirations (July 10-11, 2024, Online/On-Demand)
The “Biosimilars Training Course” conference is now available through ResearchAndMarkets.com, providing a crucial opportunity to anticipate and capitalize on the imminent growth within the biosimilars market. As numerous prominent biologics approach patent expiration in the coming years, the landscape of…
Caldera Medical Sponsors Cynisca Cycling Team for Women’s Health Empowerment
Caldera Medical, a global leader in women’s pelvic health, proudly announces its sponsorship of the Cynisca cycling team. This partnership underscores Caldera Medical’s ongoing dedication to promoting women’s health and empowerment through sports and community involvement. Cynisca Cycling, an elite…
Global Healthcare Digital Twins Market Forecast 2035
The report “Digital Twins in Healthcare Market, Industry Trends and Global Forecasts, till 2035 – Distribution by Therapeutic Area, Type of Digital Twin, Areas of Application, End Users and Key Geographical Regions” has been added to ResearchAndMarkets.com’s offerings. The global…
Epcoritamab (TEPKINLY®) Gains CHMP Approval for Follicular Lymphoma
Genmab A/S (Nasdaq: GMAB) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting conditional marketing authorization for epcoritamab (TEPKINLY®). This T-cell engaging bispecific antibody is intended as a monotherapy for…
Pulse Biosciences Announces Preliminary Results of Rights Offering
Pulse Biosciences, Inc. (Nasdaq: PLSE), leveraging its CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, disclosed today the preliminary outcomes of its recently concluded rights offering. The offering, which expired at 5:00 p.m. Eastern Time on June 26, 2024, set the…
Tebra Launches Enhanced Products for More Patient Time
Tebra, the comprehensive platform for independent healthcare providers, has announced multiple new product enhancements in the second quarter aimed at maximizing time spent with patients. This announcement coincides with the release of a recent survey revealing that 85% of independent…